These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9918075)

  • 1. Ceruloplasmin and iron: vindication after 30 years.
    Harris ED
    Nutrition; 1999 Jan; 15(1):72-4. PubMed ID: 9918075
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological functions of ceruloplasmin and their deficiency caused by mutation in genes regulating copper and iron metabolism.
    Mzhel'skaya TI
    Bull Exp Biol Med; 2000 Aug; 130(8):719-27. PubMed ID: 11177225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceruloplasmin metabolism and function.
    Hellman NE; Gitlin JD
    Annu Rev Nutr; 2002; 22():439-58. PubMed ID: 12055353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper deficiency.
    Logan JI
    J R Coll Physicians Lond; 1995; 29(5):449. PubMed ID: 8847700
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceruloplasmin, a link between copper and iron metabolism.
    Frieden E
    Ortop Travmatol Protez; 1969 Sep; 30(9):87-91. PubMed ID: 4910296
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aceruloplasminemia - a genetic iron storage disease].
    Ocran KW; Schmidt HH
    Z Gastroenterol; 2002 Jun; 40(6):479-81. PubMed ID: 12055669
    [No Abstract]   [Full Text] [Related]  

  • 7. Aceruloplasminemia.
    Gitlin JD
    Pediatr Res; 1998 Sep; 44(3):271-6. PubMed ID: 9727700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ferroportin-ceruloplasmin system and the mammalian iron homeostasis machine: regulatory pathways and the role of lactoferrin.
    Bonaccorsi di Patti MC; Cutone A; Polticelli F; Rosa L; Lepanto MS; Valenti P; Musci G
    Biometals; 2018 Jun; 31(3):399-414. PubMed ID: 29453656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Looking for a partner: ceruloplasmin in protein-protein interactions.
    Vasilyev VB
    Biometals; 2019 Apr; 32(2):195-210. PubMed ID: 30895493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 11. The heterogeneity of caeruloplasmin nd the enzymatic defect in Wilson's disease.
    RICHTERICH R; GAUTIER E; STILLHART H; ROSSI E
    Helv Paediatr Acta; 1960 Nov; 15():424-36. PubMed ID: 13741432
    [No Abstract]   [Full Text] [Related]  

  • 12. Ceruloplasmin activity in spinocerebellar degeneration.
    Badiu G
    Rev Roum Neurol; 1972; 9(1):15-8. PubMed ID: 5019763
    [No Abstract]   [Full Text] [Related]  

  • 13. Metal transport and unsafe sanctuary sites.
    Kaplan J
    J Clin Invest; 1996 Jul; 98(1):3-4. PubMed ID: 8690799
    [No Abstract]   [Full Text] [Related]  

  • 14. Not all absent serum ceruloplasmin is Wilson disease: a review of aceruloplasminemia.
    Harris ZL
    J Investig Med; 2002 Sep; 50(5):236S-238S. PubMed ID: 12227652
    [No Abstract]   [Full Text] [Related]  

  • 15. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatolenticular degeneration: yesterday, today, tomorrow].
    Lazebnik LB; Sukhareva GV
    Eksp Klin Gastroenterol; 2007; (2):55-64. PubMed ID: 17539347
    [No Abstract]   [Full Text] [Related]  

  • 17. Wilson's disease, Kayser and Fleischer's sign and Walshe's treatment.
    McIntyre N
    Br J Clin Pract; 1991; 45(2):135-40. PubMed ID: 1793699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retinal degeneration in patients with hereditary ceruloplasmin deficiency].
    Yamaguchi K
    Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1591-6. PubMed ID: 15384688
    [No Abstract]   [Full Text] [Related]  

  • 19. Predominant ataxia, low ceruloplasmin, and absent K-F rings: hypoceruloplasminemia or Wilson's disease.
    Mehta SH; Parekh SM; Prakash R; Morgan JC; Miyajima H; Sethi KD
    Mov Disord; 2010 Oct; 25(13):2260-1. PubMed ID: 20818655
    [No Abstract]   [Full Text] [Related]  

  • 20. Copper and ceruloplasmin metabolism in the LEC rat, an animal model for Wilson disease.
    Kodama H; Murata Y; Mochizuki D; Abe T
    J Inherit Metab Dis; 1998 Jun; 21(3):203-6. PubMed ID: 9686357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.